Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |